Who owns the KAVAPRO trademark?

The KAVAPRO trademark is owned by Tesseract Medical Research, LLC.

What class is the KAVAPRO trademark registered in?

The KAVAPRO trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for KAVAPRO?

The USPTO serial number for KAVAPRO is 98896720.

What is the registration number for KAVAPRO?

KAVAPRO is registered under USPTO registration number 8226030.

Sealvo

Home Search: KAVAPROKAVAPRO #98896720

Back

Updated Oct 6, 2026·14 searches this week

View on USPTO TSDR Find similar marks

KAV

USPTO Trademark Record

REGISTERED

KAVAPRO

SN 98896720·Reg 8226030·Filed Dec 11, 2024

Owner Tesseract Medical Research, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

KAVAPRO (Serial No. 98896720), Registration No. 8226030, is a registered US trademark filed on Dec 11, 2024 by Tesseract Medical Research, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 21, 2032

Mark Intelligence

KAVAPRO (Reg. #8226030) is a registered US trademark that has been protecting its owner, Tesseract Medical Research, LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 11, 2024

SERIAL

98896720

REG#

8226030

REGISTERED

Apr 21, 2026

Filing Information

StatusREGISTERED

Filing DateDec 11, 2024

Serial Number98896720

Registration No.8226030

Registration DateApr 21, 2026

Status DateApr 21, 2026

Published for OppositionApr 08, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 05, 2025

First use in commerce: May 05, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Apr 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 30, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 30, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 19, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 19, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 12, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 12, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 03, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 12, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 04, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 04, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 04, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 04, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 04, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 04, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 25, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 25, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 25, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 18, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Dec 11, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 11, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by Tesseract Medical Research, LLC

Additional USPTO filings from the same owner.

BIO

BIOTESS CAPRAMAX

99391333

Tesseract Medical Research, LLC

REGISTERED

MEL

MELATONINPRO

98895011

Tesseract Medical Research, LLC

REGISTERED

BIO

BIOTESS

98692375

Tesseract Medical Research, LLC

REGISTERED

TES

TESSMED

87237798

Tesseract Medical Research, LLC

REGISTERED

KAVAPRO

Run a conflict check

Other Marks by Tesseract Medical Research, LLC

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company